Validation of PRECISE-DAPT score for prediction of bleeding complication after coronary stent implantation in Thai populatio
Completed
- Conditions
- The patients who were underwent coronary stent implantation with DAPTPRECISE-DAPT score, Bleeding, Dual antiplatelet therapy, coronary stent implantation.
- Registration Number
- TCTR20210802004
- Lead Sponsor
- /A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 602
Inclusion Criteria
Patients with over 18 years old who were underwent coronary stent implantation and received DAPT (81-325 mg aspirin plus 75 mg/day clopidogrel, 10 mg/day prasugrel or 180 mg/day ticagrelor).
Exclusion Criteria
Patients receiving oral anticoagulant therapy, pregnancy and surgical planning within 12 months after coronary stent implantation.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method One-year out-of-hospital bleeding One-year An estimate of the hazard ratio of bleeding between two groups.
- Secondary Outcome Measures
Name Time Method One-year major adverse cardiovascular events (MACE) One-year An estimate of the hazard ratio of MACE between two groups.